Methoxy Polyethylene Glycol-Epoetin Beta Generics
Form: Solution for Injection
Strength: 25–250 mcg
Reference Brands: Mircera® (US &EU)
Category: Nephrology
Methoxy Polyethylene Glycol-Epoetin Beta, branded as Mircera®, is an advanced erythropoiesis-stimulating agent (ESA) designed for the treatment of anemia in chronic kidney disease (CKD) patients. Its long half-life enables once-monthly or biweekly dosing, improving compliance and reducing injection frequency. Approved in both the EU and US, Mircera® is widely used in dialysis and non-dialysis CKD populations. Available as prefilled syringes and vials in multiple strengths, it is an essential product in nephrology care. A strategic asset for pharmaceutical B2B partners, it offers opportunities in licensing, distribution, and hospital tenders across regulated markets with growing CKD treatment needs.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Related Products
Calcitriol Generics
Strength: Capsules:0.25 mcg, 0.5 mcg; Injection:1 mcg/mL
Form: Capsules & Injection
Reference Brands: Rocaltrol®(EU & US), Calcijex® (US)
View More Get Enquiry
Paricalcitol Generics
Strength: Capsules:1mcg, 2mcg, 4 mcg & Injection: 2mcg/mL , 5mcg/mL
Form: Capsules and Injection
Reference Brands: Zemplar®(US &EU)
View More Get Enquiry
Calcifediol(Ref.Brand: Rayaldee®(US) Generics
Strength: 30 mcg
Form: ER Oral Capsule
Reference Brands:
View More Get Enquiry
Sodium Zirconium Cyclosilicate Generics
Strength: 5g, 7g,10g sachets
Form: Powder for oral suspension
Reference Brands: Lokelma® (EU & US)
View More Get Enquiry